Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis
- 1 September 1988
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 75 (9) , 888-891
- https://doi.org/10.1002/bjs.1800750920
Abstract
A prospective randomized double-blind trial was performed comparing conventional low-dose heparin with a low molecular weight heparin fragment for thromboprophylaxis in elective general abdominal surgical patients. The first dose of the heparin fragment was given the evening before surgery, and further doses were given thereafter every evening. There were 1002 analysable patients, 826 having received correct prophylaxis. Of these 1002 patients, 64 per cent were operated on for malignant disease. A total of 20 patients died, 10 in each group. The 5·0 per cent, P = 0·02). The frequency of bleeding was 6·7 per cent among patients with correct prophylaxis with the heparin fragment (9·2–5·0 per cent, P = 0·02). The frequency of bleeding was 6·7 per cent among the heparin fragment patients and 2·7 per cent among the patients given conventional heparin (P = 0·01), but all bleeds were of minor degree and there was no difference in the reoperation rate for bleeding, or in the transfusion requirements. Local pain at the injection site was reported significantly less often among patients given the heparin fragment.Keywords
Funding Information
- Swedish Medical Research Council (00759)
This publication has 16 references indexed in Scilit:
- Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assayThrombosis Research, 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersThrombosis Research, 1986
- Low Molecular Weight Heparin (KABI2165) as Thromboprophylaxis in Elective Visceral SurgeryThrombosis and Haemostasis, 1986
- Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosisBritish Journal of Surgery, 1986
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxisJournal of Molecular Medicine, 1984
- Anticoagulant effects of two types of low molecular weight heparin administered subcutaneouslyThrombosis Research, 1983
- Planning and Analysis of Observational StudiesWiley Series in Probability and Statistics, 1983
- Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low‐dose heparinWorld Journal of Surgery, 1980